Caxton Advantage Life Sciences Fund
North America, New York, United States, New York
Description
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.
Investor Profile
Caxton Advantage Life Sciences Fund has backed more than 14 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 43% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Post Ipo Equity, Private Equity rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series C (29%)
- Post Ipo Equity (14%)
- Private Equity (14%)
- Series D (14%)
- Series E (14%)
- Series Unknown (14%)
Country Focus
- United States (79%)
- Canada (21%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Oncology
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
